{"id":"W2774243059","doi":"10.1016/j.ahj.2017.12.007","title":"The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial","year":2017,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Ottawa; Hôpital du Sacré-Cœur de Montréal; McGill University Health Centre; Institut universitaire de cardiologie et de pneumologie de Québec; University Health Network; Libin Cardiovascular Institute of Alberta; Hamilton Health Sciences; Hotchkiss Brain Institute; University of Calgary; McMaster University; University of Toronto; Population Health Research Institute; Southlake Regional Health Center","funders":"Canadian Institutes of Health Research; Universiteit Hasselt; Biotronik; National Institute of Neurological Disorders and Stroke; Daiichi-Sankyo; Covidien; AstraZeneca; Bristol-Myers Squibb; Alberta Innovates - Health Solutions; Boston Scientific Corporation; F. Hoffmann-La Roche; Heart and Stroke Foundation of Canada; Pfizer; Abbott Laboratories; Bayer; Biosense Webster; Universiteit Antwerpen; Medtronic; Boehringer Ingelheim","keywords":"Medicine; Atrial fibrillation; Rivaroxaban; Stroke (engine); Randomized controlled trial; Internal medicine; Cardiology; Antithrombotic; Catheter ablation; Population; Interim analysis; Warfarin; Surgery","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0008504254,0.0001604007,0.0003795531,0.00009632499,0.00203977,0.0003399837,0.0001146944,0.00005677421,0.00001448658],"category_scores_gemma":[0.002593775,0.0001126698,0.0007069463,0.00006103701,0.0001371465,0.000402546,0.0000323904,0.0001200316,0.000009185719],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008145097,"about_ca_system_score_gemma":0.00008806757,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002592569,"about_ca_topic_score_gemma":0.000004150207,"domain_scores_codex":[0.9984887,0.00008097352,0.0005556845,0.0002127132,0.0003535595,0.0003084202],"domain_scores_gemma":[0.9973487,0.0005165263,0.001074146,0.0003187772,0.0006303838,0.00011143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08098393,0.00002888196,0.6476211,0.00003104973,0.0006167066,5.065195e-7,0.0004291623,0.004237248,0.0008700826,0.0002032453,0.005293607,0.2596845],"study_design_scores_gemma":[0.06087025,0.007939813,0.8346173,0.00004603139,0.0006975108,0.000009155142,0.0002116105,0.009085549,0.0007348459,0.0004766413,0.08496975,0.0003415204],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9783784,0.00003316894,0.0125182,0.005052353,0.00173766,0.002174981,0.00002333738,0.00002714122,0.00005480118],"genre_scores_gemma":[0.9842881,0.0001152738,0.004810976,0.0001180198,0.01020549,0.000003655266,0.00006214641,0.00003161248,0.0003647068],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2593429,"threshold_uncertainty_score":0.9992594,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04405206787669842,"score_gpt":0.3649469929112036,"score_spread":0.3208949250345052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}